Kintara Seeking $15.0M In PIPE
socalTECH
SEPTEMBER 24, 2021
San Diego-based biotech Kintara says it is raising $15.0M in a common stock and warrant offering from unmaned "healthcare-focused institutional investors". The company--which is novel cancer therapies for patients who are failing, or are resistant to, current treatment regimens--currently trades on the Nasdaq as KTRA. Wainwright & Co.
Let's personalize your content